Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice

Biffi, Alessandra, Capotondo, Alessia, Fasano, Stefania ORCID:, del Carro, Ubaldo, Marchesini, Sergio, Azuma, Hisaya, Malaguti, Maria Chiara, Amadio, Stefano, Brambilla, Riccardo ORCID:, Grompe, Markus, Bordignon, Claudio, Quattrini, Angelo and Naldini, Luigi 2006. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. The Journal of Clinical Investigation 116 (11) , pp. 3070-3082. 10.1172/JCI28873

Full text not available from this repository.


Metachromatic leukodystrophy (MLD) is a demyelinating lysosomal storage disorder for which new treatments are urgently needed. We previously showed that transplantation of gene-corrected hematopoietic stem progenitor cells (HSPCs) in presymptomatic myeloablated MLD mice prevented disease manifestations. Here we show that HSC gene therapy can reverse neurological deficits and neuropathological damage in affected mice, thus correcting an overt neurological disease. The efficacy of gene therapy was dependent on and proportional to arylsulfatase A (ARSA) overexpression in the microglia progeny of transplanted HSPCs. We demonstrate a widespread enzyme distribution from these cells through the CNS and a robust cross-correction of neurons and glia in vivo. Conversely, a peripheral source of enzyme, established by transplanting ARSA-overexpressing hepatocytes from transgenic donors, failed to effectively deliver the enzyme to the CNS. These results indicate that the recruitment of gene-modified, enzyme-overexpressing microglia makes the enzyme bioavailable to the brain and makes therapeutic efficacy and disease correction attainable. Overall, our data provide a strong rationale for implementing HSPC gene therapy in MLD patients.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Subjects: Q Science > Q Science (General)
Publisher: American Society for Clinical Investigation
ISSN: 0021-9738
Last Modified: 27 Oct 2022 08:26

Citation Data

Cited 166 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item